This IDC study provides an assessment of the capabilities and business strategies of 10 vendors in the pharmaceutical track and trace software market. The Drug Supply Chain Security Act (DSCSA) has removed a great deal of uncertainty from the minds of pharmaceutical manufacturing and supply chain executives. They must now act decisively on software, systems, and equipment to address serialization and tracking of pharmaceutical products covered by the act, for lot level now and for item level in a few years' time. Pharmaceutical companies are looking for pharmaceutical track and trace software from vendors with strong industry-specific expertise, deep customer references, and proven experience delivering measured value to pharmaceutical organizations.
Mike Townsend, research manager for IDC Health Insights' Commercial Life Sciences, says, "Deadlines for serialization and tracking of pharmaceutical products are coming up rapidly. Track and trace software vendors are reacting with new products, capabilities, and support models to meet this growing market. Pharmaceutical companies must diligently vet these companies and solutions to find the best long-term match to meet the needs of their companies and supply chain partners."